Source:http://linkedlifedata.com/resource/pubmed/id/10329950
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5 Pt 1
|
pubmed:dateCreated |
1999-6-7
|
pubmed:abstractText |
The present study used real-time confocal microscopy to examine the effects of the beta2-adrenoceptor agonist salbutamol on regulation of intracellular Ca2+ concentration ([Ca2+]i) in myotubes derived from neonatal mouse limb muscles. Immunocytochemical staining for ryanodine receptors and skeletal muscle myosin confirmed the presence of sarcomeres. The myotubes displayed both spontaneous and ACh-induced rapid (<2-ms rise time) [Ca2+]i transients. The [Ca2+]i transients were frequency modulated by both low and high concentrations of salbutamol. Exposure to alpha-bungarotoxin and tetrodotoxin inhibited ACh-induced [Ca2+]i transients and the response to low concentrations of salbutamol but not the response to higher concentrations. Preexposure to caffeine inhibited the subsequent [Ca2+]i response to lower concentrations of salbutamol and significantly blunted the response to higher concentrations. Preexposure to salbutamol diminished the [Ca2+]i response to caffeine. Inhibition of dihydropyridine-sensitive Ca2+ channels with nifedipine or PN-200-110 did not prevent [Ca2+]i elevations induced by higher concentrations of salbutamol. The effects of salbutamol were mimicked by the membrane-permeant analog dibutyryl adenosine 3', 5'-cyclic monophosphate. These data indicate that salbutamol effects in skeletal muscle predominantly involve enhanced sarcoplasmic reticulum Ca2+ release.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Albuterol,
http://linkedlifedata.com/resource/pubmed/chemical/Bucladesine,
http://linkedlifedata.com/resource/pubmed/chemical/Caffeine,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Myosins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta,
http://linkedlifedata.com/resource/pubmed/chemical/Ryanodine Receptor Calcium Release...,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrodotoxin
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0002-9513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
276
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
C1038-45
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:10329950-Acetylcholine,
pubmed-meshheading:10329950-Adrenergic beta-Agonists,
pubmed-meshheading:10329950-Albuterol,
pubmed-meshheading:10329950-Animals,
pubmed-meshheading:10329950-Animals, Newborn,
pubmed-meshheading:10329950-Bucladesine,
pubmed-meshheading:10329950-Caffeine,
pubmed-meshheading:10329950-Calcium,
pubmed-meshheading:10329950-Cells, Cultured,
pubmed-meshheading:10329950-Immunohistochemistry,
pubmed-meshheading:10329950-Mice,
pubmed-meshheading:10329950-Microscopy, Confocal,
pubmed-meshheading:10329950-Muscle, Skeletal,
pubmed-meshheading:10329950-Myosins,
pubmed-meshheading:10329950-Receptors, Adrenergic, beta,
pubmed-meshheading:10329950-Ryanodine Receptor Calcium Release Channel,
pubmed-meshheading:10329950-Tetrodotoxin
|
pubmed:year |
1999
|
pubmed:articleTitle |
Effect of beta-adrenoceptor activation on [Ca2+]i regulation in murine skeletal myotubes.
|
pubmed:affiliation |
Departments of Anesthesiology and of Physiology and Biophysics, Mayo Clinic and Foundation, Rochester 55905, Minnesota, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|